EMA
approval
· 2020-09-18
New oral treatment for moderate to severe atopic dermatitis
Summary
The EMA announces a new oral treatment for adults with moderate to severe atopic dermatitis, representing a new therapeutic option for this condition.
Upgrade for the full analysis, importance score, and drug timeline.